Share

Actos

Actos, prescribed to treat patients with Type 2 Diabetes, has been linked to an increased risk of bladder cancer. On April 28, 2015, the U.S. District Court, overseeing the Actos litigation issued an order recognizing that Takeda, the manufacturer of Actos, has agreed to settle all bladder cancer claims.

What is Actos?

Actos, also known as Pioglitazone Hydrochloride, is an FDA approved drug used to treat Type 2 diabetes. Actos is manufactured by Takeda and Eli Lilly and is one of the most successful diabetes medication on the market.

What You Should Know

In June 2011, the FDA warned the public of an increased risk of Actos patients developing bladder cancer. The risk surfaced when an interim analysis was conducted on a ten-year epidemiological study. The results from the study revealed that patients who had the longest exposure and highest dosage of the Actos medication were at the greatest risk.

Injuries Resulting from Use of Actos

• Bladder Cancer

Actos Lawsuit Evaluation: If you or a loved one were diagnosed with bladder cancer after using Actos, you should contact The Falkowitz Law Firm immediately. You may be entitled to compensation by filing an Actos lawsuit and we can help.



© 2017 Falkowitz Law Firm, PLLC | Disclaimer
1225 Franklin Avenue, Suite 325, Garden City, NY 11530
| Phone: 888-222-3255 | 516-570-5000

Practice Areas | For Lawyers | FAQs

Law Firm Website Design by
Zola Creative


© 2015 Falkowitz Law Firm, PLLC | Disclaimer
1225 Franklin Avenue, Suite 325, Garden City, NY 11530

888-222-FALK | 888-222-3255 | 516-570-5000

For Lawyers | Practice Areas

Law Firm Website Design by
Zola Creative